{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T07:06:17Z","timestamp":1793171177239,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T00:00:00Z","timestamp":1731283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52372262"],"award-info":[{"award-number":["52372262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s10142-024-01493-x","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T13:08:35Z","timestamp":1731330515000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multi-omics analysis of the biological function of the VEGF family in colon adenocarcinoma"],"prefix":"10.1007","volume":"24","author":[{"given":"Jianqiao","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,11]]},"reference":[{"key":"1493_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s13046-021-02162-8","volume":"40","author":"Z Bian","year":"2021","unstructured":"Bian Z, Zhou M, Cui K et al (2021) SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and mir-339-5p-FOSL2-SNHG17 positive feedback loop. J Exp Clin Cancer Res 40:360. https:\/\/doi.org\/10.1186\/s13046-021-02162-8","journal-title":"J Exp Clin Cancer Res"},{"key":"1493_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jss.2014.11.028","volume":"194","author":"S Blank","year":"2015","unstructured":"Blank S, Deck C, Dreikhausen L et al (2015) Angiogenic and growth factors in gastric cancer. J Surg Res 194:420\u2013429. https:\/\/doi.org\/10.1016\/j.jss.2014.11.028","journal-title":"J Surg Res"},{"key":"1493_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"1493_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000088478","volume":"69","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69(3):4\u201310. https:\/\/doi.org\/10.1159\/000088478","journal-title":"Oncology"},{"key":"1493_CR5","first-page":"293","volume":"51","author":"O Celen","year":"2004","unstructured":"Celen O, Kahraman I, Yildirim E, Berberoglu U (2004) Correlation of vascular endothelial growth factor (VEGF) and CEA with clinicopathological variables in colorectal cancer patients. Neoplasma 51:293\u2013299","journal-title":"Neoplasma"},{"key":"1493_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401\u2013404. https:\/\/doi.org\/10.1158\/2159-8290.CD-12-0095","journal-title":"Cancer Discov"},{"key":"1493_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fbinf.2022.847629","volume":"2","author":"L Chen","year":"2022","unstructured":"Chen L, Ganz PA, Sehl ME (2022) DNA methylation, aging, and Cancer Risk: a Mini-review. Front Bioinform 2:847629. https:\/\/doi.org\/10.3389\/fbinf.2022.847629","journal-title":"Front Bioinform"},{"key":"1493_CR8","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1093\/nar\/gky286","volume":"46","author":"H-S Chiu","year":"2018","unstructured":"Chiu H-S, Mart\u00ednez MR, Komissarova EV et al (2018) The number of titrated microRNA species dictates ceRNA regulation. Nucleic Acids Res 46:4354\u20134369. https:\/\/doi.org\/10.1093\/nar\/gky286","journal-title":"Nucleic Acids Res"},{"key":"1493_CR9","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3892\/or.2016.4834","volume":"36","author":"F Cui","year":"2016","unstructured":"Cui F, Wang S, Lao I et al (2016) miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes. Oncol Rep 36:487\u2013493. https:\/\/doi.org\/10.3892\/or.2016.4834","journal-title":"Oncol Rep"},{"key":"1493_CR10","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.1158\/1078-0432.CCR-13-1217","volume":"19","author":"W Dai","year":"2013","unstructured":"Dai W, Zeller C, Masrour N et al (2013) Promoter CpG island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer. Clin Cancer Res 19:5788\u20135797. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-1217","journal-title":"Clin Cancer Res"},{"key":"1493_CR11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA et al (2019) Colorectal cancer. Lancet 394:1467\u20131480. https:\/\/doi.org\/10.1016\/S0140-6736(19)32319-0","journal-title":"Lancet"},{"key":"1493_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102414","volume":"13","author":"A Derakhshani","year":"2021","unstructured":"Derakhshani A, Hashemzadeh S, Asadzadeh Z et al (2021) Cytotoxic T-Lymphocyte Antigen-4 in Colorectal Cancer: another therapeutic side of Capecitabine. Cancers (Basel) 13:2414. https:\/\/doi.org\/10.3390\/cancers13102414","journal-title":"Cancers (Basel)"},{"key":"1493_CR13","doi-asserted-by":"publisher","first-page":"101042831770576","DOI":"10.1177\/1010428317705765","volume":"39","author":"A Elshafei","year":"2017","unstructured":"Elshafei A, Shaker O, Abd El-Motaal O, Salman T (2017) The expression profiling of serum miR-92a, miR-375, and miR-760 in colorectal cancer: an Egyptian study. Tumour Biol 39:1010428317705765. https:\/\/doi.org\/10.1177\/1010428317705765","journal-title":"Tumour Biol"},{"key":"1493_CR14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrd.2015.17","volume":"15","author":"N Ferrara","year":"2016","unstructured":"Ferrara N, Adamis AP (2016) Ten years of anti-vascular endothelial growth factor therapy. Nat Rev Drug Discov 15:385\u2013403. https:\/\/doi.org\/10.1038\/nrd.2015.17","journal-title":"Nat Rev Drug Discov"},{"key":"1493_CR15","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/nrc2524","volume":"8","author":"C Fischer","year":"2008","unstructured":"Fischer C, Mazzone M, Jonckx B, Carmeliet P (2008) FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer 8:942\u2013956. https:\/\/doi.org\/10.1038\/nrc2524","journal-title":"Nat Rev Cancer"},{"key":"1493_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3978\/j.issn.2078-6891.2012.030","volume":"3","author":"M Fleming","year":"2012","unstructured":"Fleming M, Ravula S, Tatishchev SF, Wang HL (2012) Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol 3:153\u2013173. https:\/\/doi.org\/10.3978\/j.issn.2078-6891.2012.030","journal-title":"J Gastrointest Oncol"},{"key":"1493_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/medicina55120754","volume":"55","author":"A Gnoni","year":"2019","unstructured":"Gnoni A, Licchetta A, Memeo R et al (2019) Role of BRAF in Hepatocellular Carcinoma: a rationale for future targeted Cancer therapies. Med (Kaunas) 55:754. https:\/\/doi.org\/10.3390\/medicina55120754","journal-title":"Med (Kaunas)"},{"key":"1493_CR18","first-page":"3206","volume":"61","author":"SP Gunningham","year":"2001","unstructured":"Gunningham SP, Currie MJ, Han C et al (2001) Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the Von Hippel-Lindau gene and hypoxia. Cancer Res 61:3206\u20133211","journal-title":"Cancer Res"},{"key":"1493_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H et al (2024) Cancer incidence and mortality in China, 2022. J Natl Cancer Cent 4:47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006","journal-title":"J Natl Cancer Cent"},{"key":"1493_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/path.1339","volume":"200","author":"V Hanrahan","year":"2003","unstructured":"Hanrahan V, Currie MJ, Gunningham SP et al (2003) The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol 200:183\u2013194. https:\/\/doi.org\/10.1002\/path.1339","journal-title":"J Pathol"},{"key":"1493_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1158\/2326-6066.CIR-14-0053","volume":"2","author":"FS Hodi","year":"2014","unstructured":"Hodi FS, Lawrence D, Lezcano C et al (2014) Bevacizumab plus Ipilimumab in patients with metastatic melanoma. Cancer Immunol Res 2:632\u2013642. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0053","journal-title":"Cancer Immunol Res"},{"key":"1493_CR22","doi-asserted-by":"publisher","first-page":"6876","DOI":"10.3748\/wjg.v22.i30.6876","volume":"22","author":"T Hu","year":"2016","unstructured":"Hu T, Li Z, Gao C-Y, Cho CH (2016) Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol 22:6876\u20136889. https:\/\/doi.org\/10.3748\/wjg.v22.i30.6876","journal-title":"World J Gastroenterol"},{"key":"1493_CR23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1046\/j.1365-2443.2000.00376.x","volume":"5","author":"T Ikuta","year":"2000","unstructured":"Ikuta T, Ariga H, Matsumoto K (2000) Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Genes Cells 5:913\u2013927. https:\/\/doi.org\/10.1046\/j.1365-2443.2000.00376.x","journal-title":"Genes Cells"},{"key":"1493_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041232","volume":"19","author":"Y Itatani","year":"2018","unstructured":"Itatani Y, Kawada K, Yamamoto T, Sakai Y (2018) Resistance to anti-angiogenic therapy in Cancer-alterations to Anti-VEGF pathway. Int J Mol Sci 19:1232. https:\/\/doi.org\/10.3390\/ijms19041232","journal-title":"Int J Mol Sci"},{"key":"1493_CR25","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/jso.21095","volume":"98","author":"M Kanda","year":"2008","unstructured":"Kanda M, Nomoto S, Nishikawa Y et al (2008) Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters. J Surg Oncol 98:190\u2013196. https:\/\/doi.org\/10.1002\/jso.21095","journal-title":"J Surg Oncol"},{"key":"1493_CR26","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/cgt.2016.12","volume":"23","author":"M Kazemi","year":"2016","unstructured":"Kazemi M, Carrer A, Moimas S et al (2016) VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans. Cancer Gene Ther 23:125\u2013132. https:\/\/doi.org\/10.1038\/cgt.2016.12","journal-title":"Cancer Gene Ther"},{"key":"1493_CR27","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1056\/NEJMra0706596","volume":"358","author":"RS Kerbel","year":"2008","unstructured":"Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358:2039\u20132049. https:\/\/doi.org\/10.1056\/NEJMra0706596","journal-title":"N Engl J Med"},{"key":"1493_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura T, Qian B-Z, Pollard JW (2015) Immune cell promotion of metastasis. Nat Rev Immunol 15:73\u201386. https:\/\/doi.org\/10.1038\/nri3789","journal-title":"Nat Rev Immunol"},{"key":"1493_CR29","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41571-018-0004-4","volume":"15","author":"A Koch","year":"2018","unstructured":"Koch A, Joosten SC, Feng Z et al (2018) Analysis of DNA methylation in cancer: location revisited. Nat Rev Clin Oncol 15:459\u2013466. https:\/\/doi.org\/10.1038\/s41571-018-0004-4","journal-title":"Nat Rev Clin Oncol"},{"key":"1493_CR30","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019224","volume":"99","author":"J Kudelski","year":"2020","unstructured":"Kudelski J, M\u0142ynarczyk G, Darewicz B et al (2020) Dominative role of MMP-14 over MMP-15 in human urinary bladder carcinoma on the basis of its enhanced specific activity. Med (Baltim) 99:e19224. https:\/\/doi.org\/10.1097\/MD.0000000000019224","journal-title":"Med (Baltim)"},{"key":"1493_CR31","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"J-H Li","year":"2014","unstructured":"Li J-H, Liu S, Zhou H et al (2014) starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res 42:D92-97. https:\/\/doi.org\/10.1093\/nar\/gkt1248","journal-title":"Nucleic Acids Res"},{"key":"1493_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413352","volume":"22","author":"M Ling","year":"2021","unstructured":"Ling M, Quan L, Lai X et al (2021) VEGFB promotes myoblasts proliferation and differentiation through VEGFR1-PI3K\/Akt signaling pathway. Int J Mol Sci 22:13352. https:\/\/doi.org\/10.3390\/ijms222413352","journal-title":"Int J Mol Sci"},{"key":"1493_CR33","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","volume":"34","author":"C-J Liu","year":"2018","unstructured":"Liu C-J, Hu F-F, Xia M-X et al (2018a) GSCALite: a web server for gene set cancer analysis. Bioinformatics 34:3771\u20133772. https:\/\/doi.org\/10.1093\/bioinformatics\/bty411","journal-title":"Bioinformatics"},{"key":"1493_CR34","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/s12935-020-01621-0","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Li Q, Tang D et al (2020) SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis. Cancer Cell Int 20:566. https:\/\/doi.org\/10.1186\/s12935-020-01621-0","journal-title":"Cancer Cell Int"},{"key":"1493_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.26355\/eurrev_201801_14188","volume":"22","author":"X-H Liu","year":"2018","unstructured":"Liu X-H, Wang J, Dong Y-H (2018b) The inhibitory effect of miR-375 targeting sp1 in colorectal cancer cell proliferation. Eur Rev Med Pharmacol Sci 22:405\u2013411. https:\/\/doi.org\/10.26355\/eurrev_201801_14188","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1493_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ceb.2008.12.012","volume":"21","author":"M Lohela","year":"2009","unstructured":"Lohela M, Bry M, Tammela T, Alitalo K (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21:154\u2013165. https:\/\/doi.org\/10.1016\/j.ceb.2008.12.012","journal-title":"Curr Opin Cell Biol"},{"key":"1493_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22073765","volume":"22","author":"F Lopes-Coelho","year":"2021","unstructured":"Lopes-Coelho F, Martins F, Pereira SA, Serpa J (2021) Anti-angiogenic therapy: current challenges and Future perspectives. Int J Mol Sci 22:3765. https:\/\/doi.org\/10.3390\/ijms22073765","journal-title":"Int J Mol Sci"},{"key":"1493_CR38","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1039\/c7mb00280g","volume":"13","author":"Z Ma","year":"2017","unstructured":"Ma Z, Gu S, Song M et al (2017) Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer. Mol Biosyst 13:2350\u20132361. https:\/\/doi.org\/10.1039\/c7mb00280g","journal-title":"Mol Biosyst"},{"key":"1493_CR39","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1186\/s12885-018-4442-2","volume":"18","author":"M Martini","year":"2018","unstructured":"Martini M, de Pascalis I, D\u2019Alessandris QG et al (2018) VEGF-121 plasma level as biomarker for response to anti-angiogenetic therapy in recurrent glioblastoma. BMC Cancer 18:553. https:\/\/doi.org\/10.1186\/s12885-018-4442-2","journal-title":"BMC Cancer"},{"key":"1493_CR40","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/ncb3015","volume":"16","author":"SS McAllister","year":"2014","unstructured":"McAllister SS, Weinberg RA (2014) The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nat Cell Biol 16:717\u2013727. https:\/\/doi.org\/10.1038\/ncb3015","journal-title":"Nat Cell Biol"},{"key":"1493_CR41","first-page":"455","volume":"59","author":"CS Melincovici","year":"2018","unstructured":"Melincovici CS, Bo\u015fca AB, \u015eu\u015fman S et al (2018) Vascular endothelial growth factor (VEGF) - key factor in normal and pathological angiogenesis. Rom J Morphol Embryol 59:455\u2013467","journal-title":"Rom J Morphol Embryol"},{"key":"1493_CR42","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur V, Iljasenko T, Metsalu T et al (2018) MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics 10:277\u2013288. https:\/\/doi.org\/10.2217\/epi-2017-0118","journal-title":"Epigenomics"},{"key":"1493_CR43","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41416-018-0018-9","volume":"119","author":"V Moreno","year":"2018","unstructured":"Moreno V, Alonso MH, Closa A et al (2018) Colon-specific eQTL analysis to inform on functional SNPs. Br J Cancer 119:971\u2013977. https:\/\/doi.org\/10.1038\/s41416-018-0018-9","journal-title":"Br J Cancer"},{"key":"1493_CR44","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ygyno.2006.09.031","volume":"104","author":"E Mylona","year":"2007","unstructured":"Mylona E, Alexandrou P, Giannopoulou I et al (2007) The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma. Gynecol Oncol 104:557\u2013563. https:\/\/doi.org\/10.1016\/j.ygyno.2006.09.031","journal-title":"Gynecol Oncol"},{"key":"1493_CR45","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1073\/pnas.93.6.2576","volume":"93","author":"B Olofsson","year":"1996","unstructured":"Olofsson B, Pajusola K, Kaipainen A et al (1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A 93:2576\u20132581. https:\/\/doi.org\/10.1073\/pnas.93.6.2576","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1493_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225791","volume":"20","author":"A Papachristos","year":"2019","unstructured":"Papachristos A, Kemos P, Katsila T et al (2019) VEGF-A and ICAM-1 Gene Polymorphisms as predictors of clinical outcome to First-Line Bevacizumab-based treatment in metastatic colorectal Cancer. Int J Mol Sci 20:5791. https:\/\/doi.org\/10.3390\/ijms20225791","journal-title":"Int J Mol Sci"},{"key":"1493_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143433","volume":"13","author":"D Ribatti","year":"2021","unstructured":"Ribatti D, Solimando AG, Pezzella F (2021) The Anti-VEGF(R) drug Discovery Legacy: improving Attrition Rates by breaking the vicious cycle of Angiogenesis in Cancer. Cancers (Basel) 13:3433. https:\/\/doi.org\/10.3390\/cancers13143433","journal-title":"Cancers (Basel)"},{"key":"1493_CR48","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.smim.2018.02.002","volume":"35","author":"F De Sanctis","year":"2018","unstructured":"De Sanctis F, Ugel S, Facciponte J, Facciabene A (2018) The dark side of tumor-associated endothelial cells. Semin Immunol 35:35\u201347. https:\/\/doi.org\/10.1016\/j.smim.2018.02.002","journal-title":"Semin Immunol"},{"key":"1493_CR49","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/jcb.26311","volume":"119","author":"Z Shen","year":"2018","unstructured":"Shen Z, Zhang Z, Wang X, Yang K (2018) VEGFB-VEGFR1 ameliorates Ang II-induced cardiomyocyte hypertrophy through Ca2+ -mediated PKG I pathway. J Cell Biochem 119:1511\u20131520. https:\/\/doi.org\/10.1002\/jcb.26311","journal-title":"J Cell Biochem"},{"key":"1493_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01956","volume":"11","author":"Y Song","year":"2020","unstructured":"Song Y, Fu Y, Xie Q et al (2020) Anti-angiogenic agents in Combination with Immune Checkpoint inhibitors: a promising strategy for Cancer Treatment. Front Immunol 11:1956. https:\/\/doi.org\/10.3389\/fimmu.2020.01956","journal-title":"Front Immunol"},{"key":"1493_CR51","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk D, Gable AL, Nastou KC et al (2021) The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res 49:D605\u2013D612. https:\/\/doi.org\/10.1093\/nar\/gkaa1074","journal-title":"Nucleic Acids Res"},{"key":"1493_CR52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3233\/CBM-201745","volume":"31","author":"G Wang","year":"2021","unstructured":"Wang G, Wang Y, Yang X et al (2021) The expression and diagnostic value of serum levels of EphA2 and VEGF-A in patients with colorectal cancer. Cancer Biomark 31:399\u2013408. https:\/\/doi.org\/10.3233\/CBM-201745","journal-title":"Cancer Biomark"},{"key":"1493_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109627","volume":"121","author":"J-Y Wang","year":"2020","unstructured":"Wang J-Y, Yang Y, Ma Y et al (2020) Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed Pharmacother 121:109627. https:\/\/doi.org\/10.1016\/j.biopha.2019.109627","journal-title":"Biomed Pharmacother"},{"key":"1493_CR54","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O et al (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38:W214-220. https:\/\/doi.org\/10.1093\/nar\/gkq537","journal-title":"Nucleic Acids Res"},{"key":"1493_CR55","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1007\/s12253-020-00854-8","volume":"26","author":"MZ Wojtukiewicz","year":"2020","unstructured":"Wojtukiewicz MZ, Mysliwiec M, Sierko E et al (2020) Elevated microparticles, thrombin-antithrombin and VEGF levels in Colorectal Cancer patients undergoing chemotherapy. Pathol Oncol Res 26:2499\u20132507. https:\/\/doi.org\/10.1007\/s12253-020-00854-8","journal-title":"Pathol Oncol Res"},{"key":"1493_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.soc.2017.11.001","volume":"27","author":"C Wu","year":"2018","unstructured":"Wu C (2018) Systemic therapy for Colon cancer. Surg Oncol Clin N Am 27:235\u2013242. https:\/\/doi.org\/10.1016\/j.soc.2017.11.001","journal-title":"Surg Oncol Clin N Am"},{"key":"1493_CR57","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/jop.12167","volume":"43","author":"M Yanase","year":"2014","unstructured":"Yanase M, Kato K, Yoshizawa K et al (2014) Prognostic value of vascular endothelial growth factors a and C in oral squamous cell carcinoma. J Oral Pathol Med 43:514\u2013520. https:\/\/doi.org\/10.1111\/jop.12167","journal-title":"J Oral Pathol Med"},{"key":"1493_CR58","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1172\/JCI96582","volume":"128","author":"X Zheng","year":"2018","unstructured":"Zheng X, Fang Z, Liu X et al (2018) Increased vessel perfusion predicts the efficacy of immune checkpoint blockade. J Clin Invest 128:2104\u20132115. https:\/\/doi.org\/10.1172\/JCI96582","journal-title":"J Clin Invest"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-024-01493-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-024-01493-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-024-01493-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T04:52:28Z","timestamp":1734756748000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-024-01493-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,11]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1493"],"URL":"https:\/\/doi.org\/10.1007\/s10142-024-01493-x","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,11]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Institutional Research Ethics Committee of Shandong provincial hospital. The patients\/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}